JP2008522954A5 - - Google Patents

Download PDF

Info

Publication number
JP2008522954A5
JP2008522954A5 JP2007526128A JP2007526128A JP2008522954A5 JP 2008522954 A5 JP2008522954 A5 JP 2008522954A5 JP 2007526128 A JP2007526128 A JP 2007526128A JP 2007526128 A JP2007526128 A JP 2007526128A JP 2008522954 A5 JP2008522954 A5 JP 2008522954A5
Authority
JP
Japan
Prior art keywords
seq
peptide
isolated
sequence
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007526128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008522954A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2005/001255 external-priority patent/WO2006017913A1/en
Publication of JP2008522954A publication Critical patent/JP2008522954A/ja
Publication of JP2008522954A5 publication Critical patent/JP2008522954A5/ja
Pending legal-status Critical Current

Links

JP2007526128A 2004-08-20 2005-08-22 c−Jun二量化のペプチド阻害剤及びその使用 Pending JP2008522954A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60352504P 2004-08-20 2004-08-20
PCT/AU2005/001255 WO2006017913A1 (en) 2004-08-20 2005-08-22 Peptide inhibitors of c-jun dimerization and uses thereof

Publications (2)

Publication Number Publication Date
JP2008522954A JP2008522954A (ja) 2008-07-03
JP2008522954A5 true JP2008522954A5 (enExample) 2008-09-04

Family

ID=35907184

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526128A Pending JP2008522954A (ja) 2004-08-20 2005-08-22 c−Jun二量化のペプチド阻害剤及びその使用

Country Status (6)

Country Link
US (1) US20100029552A1 (enExample)
EP (1) EP1793841B1 (enExample)
JP (1) JP2008522954A (enExample)
AU (1) AU2005274616A1 (enExample)
CA (1) CA2577995A1 (enExample)
WO (1) WO2006017913A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803765B2 (en) 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
US7270969B2 (en) 1999-05-05 2007-09-18 Phylogica Limited Methods of constructing and screening diverse expression libraries
CA2568644C (en) * 2004-06-03 2015-11-24 Phylogica Limited Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
DK1987178T3 (en) * 2006-02-20 2015-04-20 Phylogica Ltd Process for the construction and screening of peptide structure libraries
CA2663545A1 (en) * 2006-09-19 2008-03-27 Phylogica Limited Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof
WO2008154700A1 (en) * 2007-06-20 2008-12-24 Phylogica Limited Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith
CN103842809B (zh) * 2011-10-07 2016-01-13 株式会社岛津制作所 质量分析数据解析方法以及装置
WO2013116903A1 (en) 2012-02-10 2013-08-15 Phylogica Limited Methods for the characterisation of interaction sites on target proteins
EP3782638A1 (en) 2013-03-13 2021-02-24 President and Fellows of Harvard College Stapled and stitched polypeptides and uses thereof
WO2014201370A1 (en) 2013-06-14 2014-12-18 President And Fellows Of Harvard College Stabilized polypeptide insulin receptor modulators
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
CN114805527A (zh) * 2014-05-21 2022-07-29 哈佛大学的校长及成员们 Ras抑制肽和其用途
WO2016186669A1 (en) * 2015-05-20 2016-11-24 Halliburton Energy Services, Inc. Frequency comb for downhole chemical sensing
GB201522618D0 (en) * 2015-12-22 2016-02-03 Phoremost Ltd Methods of screening
BR112020004555A2 (pt) 2017-09-07 2020-09-24 Fog Pharmaceuticals, Inc. agentes que modulam funções de beta-catenina e métodos dos mesmos
CN113403304B (zh) * 2018-05-25 2022-09-30 吉林大学 副溶血性弧菌特异性结合的多肽v2及其应用
GB202203399D0 (en) * 2022-03-11 2022-04-27 Univ Bath c-jun antagonist peptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843698A (en) * 1997-04-30 1998-12-01 Universal Ventures Deleteriously affecting members of a target species by exposure to a component of symbiont or food source of an adjoiner species that is symbiotic with the target species
US6074815A (en) * 1999-03-08 2000-06-13 Universal Ventures Selection of test species for testing to identify components thereof that deleteriously affect a target species member
US7270969B2 (en) * 1999-05-05 2007-09-18 Phylogica Limited Methods of constructing and screening diverse expression libraries
US6150127A (en) * 1999-11-30 2000-11-21 Universal Ventures Causing a desirable change in a behavior pattern
US6560542B1 (en) * 2000-01-24 2003-05-06 The Cielo Institute Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
US7117096B2 (en) * 2001-04-17 2006-10-03 Abmaxis, Inc. Structure-based selection and affinity maturation of antibody library

Similar Documents

Publication Publication Date Title
JP2018171063A5 (enExample)
HRP20140109T1 (hr) Novi imunoadjuvantni spojevi na bazi flagelina i njihova upotreba
AU2022268296A1 (en) Vaccine against RSV
RU2011134596A (ru) Аналоги оксинтомодулина
JP2022541657A5 (enExample)
JP2012518035A5 (enExample)
JP2015504052A5 (enExample)
RU2009106118A (ru) Способ получения конъюгатов инсулино-подобного фактора роста i и поли(этиленгликоля)
HRP20140616T1 (hr) Peptidni analog oksintomodulina
RU2016120641A (ru) Новые полипептиды
CA2489227A1 (en) Hla-a24-restricted cancer antigen peptides
JP2011518179A5 (enExample)
WO1994029341A1 (en) Methods of enhancing bioactivity of chemokines
TWI341844B (en) Hiv fusion inhibitor peptides with improved biological properties
JP2010530903A5 (enExample)
JP2006506942A5 (enExample)
WO2006017913B1 (en) Peptide inhibitors of c-jun dimerization and uses thereof
JP2025521082A5 (enExample)
JP2007535910A5 (enExample)
JP2021522239A5 (enExample)
EP1615610A2 (en) Inhibitors of coronavirus
Olmez et al. Protein-peptide interactions revolutionize drug development
WO2009155789A1 (zh) 抑制hiv感染的多肽及其衍生物
ES2349153T3 (es) Inhibidores del virus de la hepatitis c.
CA2521038A1 (en) Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production